September 27, 2017 | The Israel Innovation Authority launched a new competitive tender to open its second biotech incubator. The incubator will be located in Northern Israel. It will serve as a space for multinational pharmaceutical industries and investment funds to support Israeli startups. The incubator will help Israel’s pharmaceutical industry by connecting investors with strategic partners, who will work together to find innovative tech projects they can help convert and reshape into new companies. A previous tender won by Israeli biotech accelerator FutuRX spurred the Authority’s decision to launch a new competitive tender. The FutuRx incubator has already invested in the establishment of 10 startups. This tender is responsible for bringing Johnson & Johnson from the US and Takeda from Japan to Israel.